Top compounds associated with response to RRN3


Feature Type Standardized
Nominal ANOVA
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.046 0.2
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA ISOX CTRPv2 pan-cancer AAC 0.043 0.2
mRNA paclitaxel UHNBreast pan-cancer AAC -0.41 0.2
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA Cyclopamine FIMM pan-cancer AAC -0.19 0.2
mRNA JQ-1 GDSC1000 pan-cancer AAC -0.043 0.2
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.043 0.2
Download CSV